IL6 and type 2 diabetes mellitus: In this study, we showed that IL-6 levels of the T2DM patients in the RSG and RSG + metformin groups were reduced following the treatments, which was consistent with findings reported by Kadoglou et al. and Erem et al. [32, 33].